Library Header Image
LSE Research Online LSE Library Services

Assessment of devices, diagnostics and digital technologies: a review of NICE medical technologies guidance

Crispi, Francisca, Naci, Huseyin, Barkauskaite, Eva, Osipenko, Leeza and Mossialos, Elias (2018) Assessment of devices, diagnostics and digital technologies: a review of NICE medical technologies guidance. Applied Health Economics and Health Policy. ISSN 1175-5652

[img] Text - Accepted Version
Download (505kB)

Identification Number: 10.1007/s40258-018-0438-y


Background: The Medical Technologies Evaluation Programme (MTEP) of NICE in England aims to evaluate medical devices that are deemed to be cost-saving or cost-neutral and produce medical technology guidance (MTG) to encourage their adoption. Objective: To review the MTGs since MTEP’s inception in 2009 until February 2017. Methods: One researcher assessed all published MTGs and extracted data on the clinical and economic evidence supporting each technology. The NICE Committee’s decision outcome for each assessment was also recorded. A qualitative analysis was performed on technologies that were not supported for adoption to identify the main drivers of the decision. Results: 31 MTGs were reviewed. The committee fully supported the medical devices in 14 MTGs, 11 were partially supported and 6 not-supported. 58% of the MTGs had no RCT data available and the main source of evidence came from non-experimental studies. There was no statistically significant difference in the average number of RCTs and non-experimental studies between the fully supported, partially supported and not supported technologies. Whilst all the fully supported MTGs demonstrated cost-saving results only 50% of the not-supported MTGs did. The sponsor estimated a higher average cost-saving than the EAC in most of cases (20/31). The qualitative evaluation suggests that the main drivers for negative decisions were the quantity or quality of studies, and cost incurring results in the economic evaluation. Conclusions: The main drivers of the decision-making process are the quality and quantity of the submitted evidence supporting the technologies, as well as the economic evaluation results.

Item Type: Article
Official URL:
Additional Information: © 2018 Springer Nature Switzerland AG
Divisions: Health Policy
Subjects: R Medicine > RA Public aspects of medicine
Sets: Departments > Health Policy
Date Deposited: 21 Nov 2018 10:59
Last Modified: 20 May 2021 00:40

Actions (login required)

View Item View Item


Downloads per month over past year

View more statistics